Evidence map›Paper›PMID 27452473›Full record

ArticleCell reports2016

Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host.

Anna Schurich, Laura J Pallett, Danyal Jajbhay, Jessica Wijngaarden, Itziar Otano, Upkar S Gill, Navjyot Hansi, Patrick T Kennedy, Eleni Nastouli, Richard Gilson and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed, 1 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 1 synthesis or guideline pooled it, 249 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Renaissance of antiviral CD8Nature reviews. Immunology · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. [Association Between T Lymphocyte Mitochondrial Function and Disease Activity in Anti-NMDAR Encephalitis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  14. Review
  15. Article
  16. Active aldehydes accelerate CD8Nature immunology · 2026
    Article
  17. Article
  18. Review
  19. Review
  20. Review

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Anna SchurichDivision of Infection and Immunity, University College London, London WC1E 6JF, UK. Electronic address: a.schurich@ucl.ac.uk.
Laura J PallettDivision of Infection and Immunity, University College London, London WC1E 6JF, UK.
Danyal JajbhayDivision of Infection and Immunity, University College London, London WC1E 6JF, UK.
Jessica WijngaardenDivision of Infection and Immunity, University College London, London WC1E 6JF, UK.
Itziar OtanoDivision of Infection and Immunity, University College London, London WC1E 6JF, UK.
Upkar S GillHepatology Unit, Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Navjyot HansiHepatology Unit, Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Patrick T KennedyHepatology Unit, Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Eleni NastouliDepartment of Clinical Virology, University College London Hospital, London WC1N 1EH, UK; Institute of Child Health, University College London, London WC1N 1EH, UK.
Richard GilsonResearch Department of Infection and Population Health, University College London, London WC1E 6JB, UK.
Christian FrezzaMRC Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge CB2 0XZ, UK.
Sian M HensonWilliam Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Mala K MainiDivision of Infection and Immunity, University College London, London WC1E 6JF, UK.
University College London · GBQueen Mary University of London · GBHutchison/MRC Research Centre · GBUniversity College Hospital · GB

Funding

Medical Research Council MR/M020126/1Wellcome Trust
6 · The paper itself

Abstract

T cells undergo profound metabolic changes to meet the increased energy demands of maintaining an antiviral response. We postulated that differences in metabolic reprogramming would shape the efficacy of CD8 T cells mounted against persistent viral infections. We found that the poorly functional PD-1(hi) T cell response against hepatitis B virus (HBV) had upregulated the glucose transporter, Glut1, an effect recapitulated by oxygen deprivation to mimic the intrahepatic environment. Glut1(hi) HBV-specific T cells were dependent on glucose supplies, unlike the more functional cytomegalovirus (CMV)-specific T cells that could utilize oxidative phosphorylation in the absence of glucose. The inability of HBV-specific T cells to switch to oxidative phosphorylation was accompanied by increased mitochondrial size and lower mitochondrial potential, indicative of mitochondrial dysfunction. Interleukin (IL)-12, which recovers HBV-specific T cell effector function, increased their mitochondrial potential and reduced their dependence on glycolysis. Our findings suggest that mitochondrial defects limit the metabolic plasticity of exhausted HBV-specific T cells.

Indexed as

AdolescentAdultCD8-Positive T-LymphocytesCytomegalovirusFemaleGlucoseGlucose Transporter Type 1GlycolysisHepatitis B virusHumansInterleukin-12MaleMiddle AgedMitochondriaOxidative PhosphorylationProgrammed Cell Death 1 ReceptorGlucoseGlucose Transporter Type 1Interleukin-12Programmed Cell Death 1 Receptor

Identifiers

PMID27452473
PMCPMC4977274
OpenAlexW2481773770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.